Robert J. Israel, Executive Vice President, Medi at PROGENICS PHARMACEUTICALS INC (PGNX), sold 3,000 shares at $7.00 ($21K) on 2015-03-13, disclosed to the SEC on 2015-03-16.
Scheduled sale ($21k) by Executive Vice President, Medi under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGNX | SELL | 2015-03-04 | $32K | — | Filing → |
| PGNX | SELL | 2015-01-13 | $14K | — | Filing → |
| PGNX | SELL | 2014-12-12 | $21K | — | Filing → |